BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-691@pharmaconomics
DTSTAMP:20260707T030451Z
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260630
SUMMARY:VRDN Approval — Lumvoa
DESCRIPTION:A final FDA approval decision on Lumvoa for thyroid eye disease is expected Jun 29\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1590750/000119312526286273/d164211dex991.htm\n\nTrack it: https://pharmaconomics.com/e/691
URL:https://pharmaconomics.com/e/691
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VRDN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR